Stay updated on Bristol Myers Squibb Press Releases
Sign up to get notified when there's something new on the Bristol Myers Squibb Press Releases page.

Latest updates to the Bristol Myers Squibb Press Releases page
- Check22 days agoChange DetectedAdded two November 2025 press releases: 'Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers' (Nov 18, 2025) and 'Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers' (Nov 17, 2025). Removed older items from October 2025, including the SystImmune/BMS Phase I results from ESMO 2025 and philanthropy-related news such as the Bristol Myers Squibb Foundation donation announcement.SummaryDifference9%

- Check30 days agoChange DetectedAdded two new press releases: 'Update on Phase 3 Librexia ACS Trial' (Nov 14, 2025) and 'Sarah Cannon Research Institute and Bristol Myers Squibb Expand Strategic Collaboration to Accelerate Patient Enrollment and Broaden Access to Innovative Cancer Research' (Nov 12, 2025). Removed two older items: 'Bristol Myers Squibb to Present Data at ESMO 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types' (Oct 13, 2025) and 'Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics' (Oct 10, 2025).SummaryDifference9%

- Check37 days agoChange DetectedNew items add debt pricing and data/tender-offer announcements, while several regulatory and program updates are removed. Overall, the list of recent press releases shown on the Bristol Myers Squibb page changes significantly.SummaryDifference8%

- Check44 days agoChange DetectedNew October 2025 press releases were added, including the Third Quarter Financial Results for 2025 and other updates; older releases from July–August 2025 were removed from the list.SummaryDifference14%

- Check129 days agoChange DetectedThe page now includes news about Bristol Myers Squibb's application for Breyanzi being accepted for priority review by the FDA for a new cancer type, while previous information about their presentation at EHA 2025 has been removed.SummaryDifference26%

- Check136 days agoChange DetectedThe webpage has updated its content to include Bristol Myers Squibb's second quarter financial results for 2025 and the establishment of a new company focused on immunology therapies, while removing previous announcements about reporting results and late-breaking trial data.SummaryDifference100%

Stay in the know with updates to Bristol Myers Squibb Press Releases
Enter your email address, and we'll notify you when there's something new on the Bristol Myers Squibb Press Releases page.